Terms: = Ovarian cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT AND Treatment
3 results:
1. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
2. lrp1b Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin treatment in ovarian cancer.
Dionísio de Sousa IJ; Cunha AI; Saraiva IA; Portugal RV; Gimba ERP; Guimarães M; Prazeres H; Lopes JM; Soares P; Lima RT
Pathobiology; 2021; 88(6):400-411. PubMed ID: 34689147
[TBL] [Abstract] [Full Text] [Related]
3. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract] [Full Text] [Related]
